Inflammatory and immune etiology of type 2 diabetes

Area of Science:

• Immunology
• Metabolic Disorders
• Endocrinology

Background:

• Type 2 diabetes (T2D) is a global health crisis with unclear causative factors.
• Obesity and nonalcoholic fatty liver disease (NAFLD) are linked to T2D, but many obese individuals do not develop diabetes, indicating unknown mechanisms.
• Immune system dysregulation is increasingly implicated in metabolic diseases.

Purpose of the Study:

• To investigate the hypothesis that specific immune profiles predispose individuals to T2D.
• To explore the role of immune cell heterogeneity in metabolic organs in T2D pathogenesis.
• To identify potential immune-based biomarkers for predicting T2D risk.

Main Methods:

• Analysis of immune cell populations, specifically monocytes and macrophages, in circulation and key metabolic tissues (liver, white adipose tissue, pancreas).
• Characterization of immune cell phenotypes and functions in relation to metabolic status.
• Correlation of immune profiles with T2D development and metabolic dysfunction.

Main Results:

• Significant heterogeneity observed in monocyte and macrophage populations across different metabolic organs.
• Distinct immune profiles identified in individuals with varying degrees of metabolic health, including obese non-diabetic subjects.
• Evidence suggesting specific immune cell subsets contribute to the development of T2D.

Conclusions:

• Immune cell heterogeneity in metabolic organs plays a crucial role in T2D pathogenesis.
• Immune profiling may offer novel strategies for predicting T2D risk.
• Targeting specific immune pathways could represent a future therapeutic approach for T2D and associated metabolic disorders.